Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Clearside Biomedical, Inc. | clsd-ex321_8.htm |
| EX-31.2 - EX-31.2 - Clearside Biomedical, Inc. | clsd-ex312_9.htm |
| EX-31.1 - EX-31.1 - Clearside Biomedical, Inc. | clsd-ex311_7.htm |
| EX-10.32 - EX-10.32 - Clearside Biomedical, Inc. | clsd-ex1032_499.htm |
| EX-10.31 - EX-10.31 - Clearside Biomedical, Inc. | clsd-ex1031_479.htm |
| EX-10.30 - EX-10.30 - Clearside Biomedical, Inc. | clsd-ex1030_500.htm |
| EX-10.29 - EX-10.29 - Clearside Biomedical, Inc. | clsd-ex1029_477.htm |
| EX-10.26 - EX-10.26 - Clearside Biomedical, Inc. | clsd-ex1026_501.htm |
| EX-10.24 - EX-10.24 - Clearside Biomedical, Inc. | clsd-ex1024_476.htm |
| EX-10.23 - EX-10.23 - Clearside Biomedical, Inc. | clsd-ex1023_475.htm |
| EX-4.4 - EX-4.4 - Clearside Biomedical, Inc. | clsd-ex44_474.htm |
| 10-K - 10-K - Clearside Biomedical, Inc. | clsd-10k_20191231.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
|
|
(1) |
Registration Statement (Form S-8 No. 333-212014) pertaining to the 2011 Stock Incentive Plan, as amended, Stock Option Awards, 2016 Equity Incentive Plan, and 2016 Employee Stock Purchase Plan of Clearside Biomedical, Inc., |
|
|
(2) |
Registration Statement (Form S-8 No. 333-216750) pertaining to the 2016 Equity Incentive Plan and 2016 Employee Stock Purchase Plan of Clearside Biomedical, Inc., |
|
|
(3) |
Registration Statement (Form S-3 No. 333-219132) of Clearside Biomedical, Inc., |
|
|
(4) |
Registration Statement (Form S-8 No. 333-224826) pertaining to the 2016 Equity Incentive Plan and 2016 Employee Stock Purchase Plan of Clearside Biomedical, Inc., and |
|
|
(5) |
Registration Statement (Form S-8 No. 333-231383) pertaining to the 2016 Equity Incentive Plan of Clearside Biomedical, Inc., |
of our report dated March 13, 2020, with respect to the financial statements of Clearside Biomedical, Inc. included in this Annual Report (Form 10-K) of Clearside Biomedical, Inc. for the year ended December 31, 2019.
/s/ Ernst & Young LLP
Atlanta, Georgia
March 13, 2020